A comparative study of bioactive properties of wild and commercial Achillea millefolium L. by Dias, Maria Inês et al.
~ 
~ 
: 1st symposium on 
; MEDICINAL CHEMISTRY 
~ 
~ 
Universodade do Minho 
100 
f 
Brag a 
Campus de Gua ltar 
17 May 2013 
PC30 
A comparative study of bioactive properties of wild and commercial 
Achillea millefolium L. 
Maria lnes Diasa.b, Lillian Barrosa, Ana Maria Carvalhoa, Rita C. Alvesb, M. Beatriz P.P. Oliveirab, 
lsabel C.F.R. Ferreiraa: 
a Cent re de lnves tiga<;:ao de Mon tanha (C IMO) , ESA, Institu te Politecn ico de Brag anr;a, 
Campus de Santa Apol6nia, Apart ado 1172, 5301-855 Braganr;a , Portugal; 
bREQUIMTE, Oepartamento de Ciencias Quimicas, Faculdade de Farmacia da 
Universidade do Porto , Rua de Jorge Viterbo Ferreira , 228, 4050-313 Porto , Portugal ; 
•;terreira@ipb.pt 
Achillea millefolium L. , commonly known as yarrow, is a medicinal plant with high bioactive value. 
Its infusion, decoction and alcoholic extract are widely used in Europe to treat digestive and 
intestinal problems, but also due to their antitumor, antimicrobial, anti-inflammatory and 
antioxidant properties [1]. In the present work, methanolic extract, infusion and decoction of wild 
and commercial yarrow were studied for their antioxidant properties and antitumor potential, 
evaluated by free radicals scavenging activity, reducing power and lipid peroxidation inhibition and 
by estimation of the growth inhibitory activity in human tumor cell lines, respectively. Overall, 
cultivated yarrow showed the highest antioxidant activity, presenting the lowest EC50 values. 
Decoctions of both samples revealed the highest DPPH scavenging activity (0.25 and 0.20 
mg/ml, respectively) , 13-carotene bleaching inhibition {0.18 and 0.22 mg/ml) and TBARS 
inhibition (0.04 and 0.08 mg/ml), while infusions presented the highest reducing power (0.12 and 
0.13 mg/ml). The samples showed a higher lipid peroxidation inhibition, but a lower DPPH 
scavenging activity than methanolic extract of A. millefolium from Turkey (892.67 and 45.60 
11g/ml, respectively) [2]. The infusion of wild yarrow showed the highest potential against breast 
(MCF-7; 8 150=17.04 1-Jg/ml) and hepatocellular (HepG2; 37.60 1-Jg/ml) carcinoma cell lines, while 
the methanolic extract of commercial yarrow was most potent against non-small cell lung (NCI-
H460; 26.64 IJg/ml) , colon (HCT-15, 13.90 1-Jg/ml) and cervical (Hela, 19.68 IJg/ml) carcinoma 
cell lines. The results obtained with the decoction and infusion of cultivated yarrow against MCF-7 
line are consistent with the ones reported with ethanolic extract of A. millefolium from Iran 
(8150=64.078 1-Jg/ml) [3].This is a groundbreaking study on the comparison of different extracts of 
A. millefolium, showing that medicinal plants can be used not only in traditional medicine but also 
as a source of bioactive products, namely antioxidants and antitumorals. 
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